The New Jersey Chapter of the American College of Emergency Physicians (ACEP) is honoring the memory of those lost in 9/11 with the Safe Citizens Day program. Rachelle A. Greenman, MD, FACEP, Cooper Emergency Medicine physician, is the past president of the NJ Chapter of the ACEP and was instrumental in launching the initiative in 2014. The goal of the day is to make a commitment to being better citizens by teaching, or by learning ways to help ourselves, our families, our friends and our neighbors to survive times of unexpected challenges. Read more.
Study Reviews Guidelines for the Treatment of Men With Low Testosterone Levels – Data Supports Use of Current Standards
Allen D. Seftel, MD, FACS, Head of the Division of Urology at Cooper University Health Care, has published the results of a study in the August issue of Mayo Clinic Proceedings, a leading medical journal.
Dr. Seftel’s study, “Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis,” reviewed case data to determine if clinical evidence continues to support the use of guidelines established in 2010 to treat male hypogonadism (“Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline,”) or if modifications to some of the guidelines were warranted. Read more.
Cooper University Health Care (CUHC) has entered into an alliance with The Memorial Hospital of Salem County (MHSC) to provide physician coverage for the Emergency Department and Hospitalist program at the Salem County hospital.
As of July 1, 2015, Cooper physicians are staffing the MHSC Emergency Department 24 hours a day, seven days a week. All physicians are board-certified/board–eligible in emergency medicine and will work in conjunction with the Cooper Hospitalists, who are already providing care to MHSC patients. Read more.
Innovative Technology Reduces Stroke Risk, Alternative to Long-Term Medication Use
On May 11, 2015, a multidisciplinary team at the Cooper Heart Institute became the first in South Jersey and the Philadelphia region to implant the newly approved WatchmanTM Left Atrial Appendage Closure device, providing patients with non-valvular atrial fibrillation (AF) an alternative to long-term “blood-thinning” warfarin medication. The medical team successfully performed three cases on the first day. Read more.